Download Files:
Products Details
Product Description
– Cav 3.2 inhibitor 1 is a T-type calcium channel inhibitor with little binding affinity to dopamine D2 receptors. Cav 3.2 inhibitor 1 can be used for the research of somatic and visceral pain[1].
Web ID
– HY-151450
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C32H39N3O
References
– [1]Yoshihito Kasanami, et al. Discovery of pimozide derivatives as novel T-type calcium channel inhibitors with little binding affinity to dopamine D 2 receptors for treatment of somatic and visceral pain. Eur J Med Chem. 2022 Aug 27;243:114716.
CAS Number
– 2878598-59-3
Molecular Weight
– 481.67
SMILES
– O=C1N(CCCCC2=CC=CC=C2)C3=CC=CC=C3N1C4CCN(CCCCC5=CC=CC=C5)CC4
Clinical Information
– No Development Reported
Research Area
– Inflammation/Immunology; Neurological Disease
Solubility
– 10 mM in DMSO
Target
– Calcium Channel
Pathway
– Membrane Transporter/Ion Channel;Neuronal Signaling
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
